255 related articles for article (PubMed ID: 23425904)
1. [The targets research of non-small cell lung cancer targeted therapy].
Xue H; Zhou S; Lu W; Zhao Z
Zhongguo Fei Ai Za Zhi; 2013 Feb; 16(2):107-13. PubMed ID: 23425904
[No Abstract] [Full Text] [Related]
2. [Progress of related targets in LKB1 signaling pathway for non-small cell lung cancer therapy].
Wang J; Han R; Zhong D
Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):435-8. PubMed ID: 22814264
[No Abstract] [Full Text] [Related]
3. [Advances of driver gene and targeted therapy of non-small cell lung cancer].
Zhang D; Huang Y; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):750-4. PubMed ID: 25342042
[TBL] [Abstract][Full Text] [Related]
4. Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target!
Codacci-Pisanelli G; Frati L; Mini E
J Chemother; 2011 Aug; 23(4):245-6. PubMed ID: 21803707
[No Abstract] [Full Text] [Related]
5. Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer.
Rothschild SI; Gautschi O; Lara PN; Mack PC; Gandara DR
Curr Opin Oncol; 2011 Mar; 23(2):150-7. PubMed ID: 21119513
[TBL] [Abstract][Full Text] [Related]
6. Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
Zhang S; Sun Y
EBioMedicine; 2020 Apr; 54():102718. PubMed ID: 32268269
[No Abstract] [Full Text] [Related]
7. The tissue is the issue: personalized medicine for non-small cell lung cancer.
Hirsch FR; Wynes MW; Gandara DR; Bunn PA
Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
[TBL] [Abstract][Full Text] [Related]
8. Personalised medicine for nonsmall cell lung cancer.
Mascaux C; Tomasini P; Greillier L; Barlesi F
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29141962
[TBL] [Abstract][Full Text] [Related]
9. In search of the philosopher’s stone: The ALCHEMIST study for lung cancer.
Veeramachaneni N; Wigle D; Boughey JC
Bull Am Coll Surg; 2017 Mar; 102(3):37-8. PubMed ID: 28920661
[No Abstract] [Full Text] [Related]
10. Update on afatinib-based combination regimens for the treatment of EGFR mutation-positive non-small-cell lung cancer.
Bennouna J
Future Oncol; 2017 Sep; 13(21):1829-1833. PubMed ID: 28657354
[No Abstract] [Full Text] [Related]
11. Targeted agents in the management of small cell lung cancer - present and future.
Srivastava R; Lebowicz Y; Jamil MO
Drugs Today (Barc); 2018 Aug; 54(8):479-488. PubMed ID: 30209442
[TBL] [Abstract][Full Text] [Related]
12. [Research Advances of Ang-2 in Non-small Cell Lung Cancer].
Hua X; Zhu X
Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):868-874. PubMed ID: 30454550
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy.
Biello F; Burrafato G; Rijavec E; Genova C; Barletta G; Truini A; Coco S; Bello MG; Alama A; Boccardo F; Grossi F
Anticancer Agents Med Chem; 2016; 16(9):1142-54. PubMed ID: 26845137
[TBL] [Abstract][Full Text] [Related]
14. [The molecular markers related to personalized therapy of non-small cell lung cancer].
Guo N; Yu C; Yu C
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):292-6. PubMed ID: 21426677
[No Abstract] [Full Text] [Related]
15. [Research Progress of Targeted Therapy for BRAF Mutation
in Advanced Non-small Cell Lung Cancer].
Liu X; Zhong D
Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):635-640. PubMed ID: 30172272
[TBL] [Abstract][Full Text] [Related]
16. Emerging gene mutation targets in lung cancer.
Johnson BE
Clin Adv Hematol Oncol; 2015 Dec; 13(12):812-4. PubMed ID: 27058846
[No Abstract] [Full Text] [Related]
17. Targeting the MET gene for the treatment of non-small-cell lung cancer.
Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
[TBL] [Abstract][Full Text] [Related]
18. [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
Dong M; Li T; Chen J
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):116-120. PubMed ID: 29526179
[TBL] [Abstract][Full Text] [Related]
19. [Targeted therapies in non-small cell lung cancer in 2014].
Leduc C; Besse B
Rev Mal Respir; 2015 Feb; 32(2):182-92. PubMed ID: 25704901
[TBL] [Abstract][Full Text] [Related]
20. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
